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Arthropod vectors transmit organisms that cause many 
emerging and reemerging diseases, and their control is 
reliant mainly on the use of chemical insecticides. Only a 
few classes of insecticides are available for public health 
use, and the increased spread of insecticide resistance is 
a major threat to sustainable disease control. The primary 
strategy for mitigating the detrimental effects of insecticide 
resistance is the development of an insecticide resistance 
management plan. However, few examples exist to show 
how to implement such plans programmatically. We de-
scribe the formulation and implementation of a resistance 
management plan for mosquito vectors of human disease 
in Zambia. We also discuss challenges, steps taken to ad-
dress the challenges, and directions for the future.
Emerging and reemerging infectious diseases are of-ten transmitted by arthropod vectors (1,2). A primary 
strategy to reduce vectorborne disease transmission is the 
use of insecticides for public health. However, resistance 
to insecticides has appeared in all major insect vectors of 
human disease (3) and has rapidly increased in prevalence 
and intensity over the past decade (4). Insecticide resis-
tance is worrisome, in part because it has repeatedly been 
implicated as a cause of disease resurgence, particularly for 
malaria (5–8).
Although the spread of resistance in a popula-
tion of organisms challenged by a drug or insecticide 
is inevitable, the public health community has not yet 
taken the steps necessary to safeguard the limited num-
ber of insecticides available. Consequently, their con-
tinued efficacy is at risk (9), setting the stage for re-
emergence of vectorborne diseases in locations where 
insecticide-based control measures are implemented. In 
response to this concern, the World Health Organization 
published the Global Plan for Insecticide Resistance 
Management (GPIRM) in 2012 (10). This document pro-
vides vectorborne disease control programs and other 
stakeholders with a strategic direction for approaching 
the resistance crisis.
The GPIRM outlines the need for increased resis-
tance monitoring, data management capacity, and imple-
mentation of strategies to manage insecticide resistance. 
The responsibility for implementing this management 
plan lies with disease-endemic countries, with support 
from their global partners. Among the challenges in car-
rying out these recommendations are lack of options for 
insecticide rotations (the primary strategy for curbing 
spread of resistance), inconsistent resistance monitor-
ing procedures, reluctance to share resistance data, and 
lack of data management capacity in disease-endemic 
countries (11). In addition, a reliance on donor funding, 
which can be unpredictable, threatens the sustainability 
of enacted plans.
By 2014, only a few countries had established insecti-
cide resistance management plans (IRMPs) and incorporat-
ed them into operational malaria vector control programs 
(11). However, no country has documented how it formu-
lated or executed these policies and addressed challenges. 
To realize fully the vision of the GPIRM, national malaria 
control programs must share experiences regarding policy-
making processes. We report on the formulation and imple-
mentation of a new insecticide resistance management plan 
in Zambia during 2009–2014.
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Local Setting
Because of the increased political commitment since the 
Abuja Declaration in 2001, funding for malaria control has 
increased (12). The widespread use of insecticide-based 
vector control subsequently reemerged in many malaria-
endemic countries, including Zambia. In 2000, the private 
sector reintroduced indoor residual spraying (IRS) with 2 
classes of insecticides, DDT and pyrethroids, in 2 districts 
in Zambia’s Copperbelt province (13). The success of these 
IRS programs led Zambia’s National Malaria Control Cen-
tre (NMCC) to implement IRS and distribution of long-
lasting insecticidal nets (LLINs) (14). IRS use was scaled 
up from 5 districts in 2003 to all 72 districts by 2011 (15) 
(the total number of Zambia districts increased to 105 in 
2013). Countrywide mass distribution of LLINs has oc-
curred since 2005; currently, 72% of households own >1 
LLIN (16). For 9 years after IRS was introduced in 2000, 
vector control relied exclusively on 2 insecticide classes 
with 1 mode of action (i.e., both DDT and pyrethroids 
target the voltage-gated sodium channel of nerve cells to 
cause death of the insect). However, in 2009, resistance to 
both insecticide classes was detected in the major malaria 
and lymphatic filariasis vectors (17).
After this resistance was detected, the NMCC formed 
the Insecticide Resistance Management Technical Work-
ing Group (IRMTWG) in 2010. This group provides a 
foundation for the policy development process by coordi-
nating policy formulation, implementation, and evaluation. 
The IRMTWG is multisectoral and comprises members 
of government, nongovernment, and private organizations 
having a vested interest in vector control (Figure 1). A 
subset of IRMTWG members forms the Technical Advi-
sory Committee (TAC), which aids the NMCC in interpret-
ing the results of the implementation process and provides 
recommendations about the most appropriate actions. The 
NMCC serves as the secretariat of the IRMTWG and co-
ordinates the implementation of entomologic surveillance 
and resistance monitoring in the country.
In April 2011, through a series of conference calls, 
the IRMTWG defined the following policy objectives: 1) 
gather more phenotypic resistance data through partners 
serving as channels of information for different parts of the 
country, and establish a sustainable monitoring protocol; 
2) determine the underlying mechanisms involved in resis-
tance of all the major vectors in Zambia; 3) establish and 
maintain a database for all insecticide resistance data; and 
4) develop an IRMP informed by data and agreed on by all 
stakeholders. The group recognized that to achieve the last 
objective, objectives 1–3 must be first realized. Therefore, 
implementation of the policy was envisioned as a multi-
phased process.
Objective 1: Expand Resistance Data
Although initial data presented to the incipient IRMTWG 
were limited, they highlighted insecticide resistance in 
Zambia, in particular, DDT resistance in areas where this 
insecticide was used (17). In addition, 2 obstacles became 
apparent. First, the available data revealed only a small 
portion of the insecticide resistance in the country, but 
the data could be expanded through the collaboration of 
other stakeholders, including research (local and interna-
tional), private (mining and agricultural), nongovernment 
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Figure 1.	Composition	of	the	
Insecticide	Resistance	Management	
(IRM)	Technical	Working	Group	
and the Technical Advisory 
Committee	in	Zambia	and	roles	
of	member	organizations.	NGOs,	
nongovernment	organizations;	
WHO,	World	Health	Organization.
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organizations, and insecticide companies. Second, even if 
all partners agreed to share data, a concerted and organized 
effort to collect more data was necessary.
The formation of the IRMTWG and its inclusion of 
all stakeholders assuaged the doubts of many of its partici-
pants about sharing data. Discussions about data ownership 
and use continue to the present day, and all participants 
agree that data-sharing does not prevent publication. In 
addition, partners are willing to share data because of the 
NMCC’s role in leading the process. Their willingness to 
share data might not have occurred if the process were led 
by an outside organization. With data from the entire coun-
try in hand, the IRMTWG and TAC could make informed 
recommendations about which locations needed additional 
data and which organization was in the best position to col-
lect that data.
As a result of data-sharing and increased monitoring 
efforts, the cumulative number of geographic foci with 
resistance data increased at a staggering pace (Figure 2), 
largely because of efficient interactions between the IR-
MTWG and policy implementers (i.e., the NMCC and the 
Zambia Integrated Systems Strengthening Program, sup-
ported by the US government’s President’s Malaria Ini-
tiative [PMI]). During the annual meeting, the IRMTWG 
collates and interprets the available resistance data and 
provides guidance about locations for focusing monitoring 
efforts for the following year. This work has resulted in a 
better understanding of the resistance profiles of the major 
malaria vectors throughout the country.
Sustained Monitoring and Evaluation
The insecticide resistance profile for many areas of the 
country was determined, each at a specific time, during 
2011–2014. However, 9 sites in districts where IRS was 
being implemented were selected for longitudinal moni-
toring of mosquito populations. In these sites, light traps 
(developed by the US Centers for Disease Control and Pre-
vention [CDC]) and pyrethrum spray catches were used 
to monitor mosquito density and behavior; insecticide 
bioassays (18) were performed every 6 months to monitor 
prevalence of resistance. In 2014, the IRMTWG decided 
that the NMCC should increase the number of sites be-
ing monitored from 9 to 24 sentinel sites spread across the 
country. When resistance is detected by using a diagnostic 
dose, quantifying the strength of that resistance and de-
termining how the resistance may impact vector control 
are needed. In Burkina Faso, the strength of resistance 
increased significantly over just 3 years (19), leading to 
decreased effectiveness of bed nets. Consequently, CDC 
bottle bioassays (20) will be used to measure intensity of 
resistance in the original 9 sentinel sites.
The primary challenge in implementing this monitor-
ing scheme is the limited financial and human resources 
that any single organization has to devote to such a large 
task. This difficulty was alleviated when the NMCC took 
the lead in the insecticide resistance management process. 
Although funding comes from different sources (e.g., gov-
ernment of Zambia, World Health Organization, PMI, UK 
Department for International Development, and the Global 
Fund), having the NMCC at the helm helps divide moni-
toring procedures among partners in an organized fashion 
and facilitates the standardization of monitoring protocols 
across sites.
Objective 2: Determine Mechanisms of Resistance
With development of molecular techniques for resistance 
detection, programs can now detect the presence of re-
sistance genes in vectors and monitor how gene frequen-
cies change over time. Both Equatorial Guinea (21) and 
Zambia (22) have shown the value of using rapid mo-
lecular assessment of local vectors to inform operational 
decision-making.
Details of insecticide resistance in Zambia and the 
means of data collection have been documented (17,22). 
Briefly, Anopheles gambiae mosquitoes are resistant to 
DDT and pyrethroids because of the target site mutation 
kdr (knockdown resistance) L1014F and elevated P450 
and glutathione S-transferase detoxification enzymes; An. 
funestus mosquitoes are resistant to carbamates and py-
rethroids because of elevated P450. In An. funestus mos-
quitoes, this resistance mechanism is the same one that 
led to the failure of the pyrethroid-based control program 
in South Africa during the 1990s (23) and that has been 
detected in Malawi (24) and Mozambique (25). These 
findings greatly influenced the decision-making process 
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Figure 2. Increase in the number of geographic locations 
producing data on insecticide resistance in malaria vectors, 
Zambia,	2010–2014.
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surrounding the IRM strategy in Zambia; they confirmed 
that pyrethroids should no longer be included in insec-
ticide rotations because of the metabolic mechanism of 
resistance (10).
Objective 3: Establish a Central Data Repository
Reliable and available resistance-monitoring data are es-
sential for evidence-based decision-making. The Disease 
Data Management System (DDMS) entomology module 
(26) is used for collating the data, and evaluation of the 
DDMS in Zambia and other countries has been reported 
(27). Historical data since 2011 were imported into the 
DDMS from legacy systems (typically Excel or Access 
[Microsoft, Redmond, WA, USA]), and data from ongo-
ing collections have been entered into the system directly. 
The DDMS accepts all data used by vectorborne disease 
control programs and generates reports in many formats. 
When evaluating resistance data, the DDMS has become 
a valuable tool for the IRMTWG and TAC. Information is 
more easily collated and mapped than previously and en-
ables more informed decision-making and close monitor-
ing of the IRM policy development process.
The primary challenge in adopting a system like the 
DDMS has been a lack of data management capacity within 
the NMCC. Components of entomologic monitoring and 
evaluation, such as data management and decision support 
systems like the DDMS, must have allocations of sufficient 
financial and human resources if they are to realize their 
full potential in guiding disease control policy. The NMCC 
and the Zambia Integrated Systems Strengthening Program 
sought technical assistance for training end users, from data 
entry to management levels, so that all parties were com-
petent in using the system. The annual IRMTWG meetings 
that require access to the data and reports generated from 
the DDMS provide pressure to use the system (i.e., enter 
and check the data) throughout the year.
Objective 4: Policy Change and the IRMP
The primary goal of the IRMTWG annual meetings is to 
interpret resistance data to make informed decisions about 
which insecticides to deploy for IRS during the next spray 
season. During 2011–2013, when implementing partners 
were strategically collecting resistance data to better in-
form the IRM strategy, the TAC had to make decisions 
about IRS in Zambia, although some parts of the country 
were not comprehensively supported by data. In 2011, the 
first major change to the IRS strategy was implemented: 
withdrawing DDT and introducing carbamates and organo-
phosphates. By using the resistance data available at the 
time, TAC decided that carbamates should be deployed 
in Northern, Muchinga, Luapula, and Copperbelt prov-
inces, whereas organophosphates would be used in Eastern 
province and pyrethroids in the rest of the country. After 
the necessary legislative and regulatory approvals were 
obtained from the Zambia Environmental Management 
Agency, procedures for procuring these insecticides imme-
diately commenced. Both the PMI and the government of 
Zambia, which supported the IRS operations, issued bids 
for contracts, and contending bidders registered with the 
Zambia Environmental Management Agency as a regula-
tory compliance procedure for supplying carbamates and 
organophosphates. To operationalize the new policy, per-
sonnel in public and private sectors conducted train-the-
trainer workshops and cascade trainings that emphasized 
safe use, storage, and disposal of carbamates and organo-
phosphates (28).
In 2012, the TAC reviewed the latest data from all 
IRMTWG member organizations and advised the NMCC 
to rotate organophosphates with carbamates in Northern, 
Muchinga, and Copperbelt provinces for the 2012 IRS 
campaign. The same insecticides used in 2011 were recom-
mended in the other provinces because of lack of available 
options or lack of data to support decisions. Unfortunately, 
this strategy was not executed, and Northern, Muchinga, 
and Copperbelt provinces were sprayed with carbamates 
again in 2012 because of an insufficient amount of the new 
formulation of the organophosphate pirimiphos-methyl, 
Actellic 300CS (Syngenta, Basil, Switzerland), being pro-
duced by the supplier. In addition, because of the paucity 
of data in the western half of the country, the TAC advised 
that efforts should be made to collect resistance data in 
these areas.
In 2013, efforts to collect resistance data in North-
Western and Western provinces were increased to better 
inform decision-making. The available data indicated that 
resistance to all classes of insecticides except the organo-
phosphates was present in all areas of Zambia. Therefore, 
the TAC recommended that the NMCC spray the entire 
country with the organophosphate pirimiphos-methyl in 
2013. However, only Luapula, Northern, Muchinga, and 
Eastern provinces were sprayed in 2013 because of in-
creased cost. The TAC recommended continued monitor-
ing of resistance across the country, with additional efforts 
in Luapula province, where resistance patterns to pyre-
throids appeared to be inconsistent.
With the resistance profile in all areas of the country 
established, the insecticide resistance database in use, and 
regular IRMTWG and TAC meetings being held, the culmi-
nation of several years of hard work was evident in 2014. In 
preparation for the annual IRMTWG and TAC meeting in 
May, the first official IRMP was drafted and distributed to 
members in March 2014. Over the course of the meetings, 
the IRMP was revised and modified, resulting in a living 
document that will guide the control program about IRM 
strategies, monitoring and evaluation, and operational re-
search priorities (Zambia Ministry of Health, unpub. data). 
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The plan highlights the necessity of avoiding pyrethroids 
for IRS because of widespread, metabolically mediated re-
sistance. In addition, it recommends that organophosphates 
be used in rotation with DDT (where An. funestus or An. 
arabiensis mosquitoes are the primary vectors) to control 
vector populations effectively while simultaneously reduc-
ing selection pressure of any specific active ingredient. 
The plan highlights several knowledge and resource gaps, 
including the limited number of insecticides available for 
IRS, the limited human resource and institutional capac-
ity to deliver monitoring and evaluation, and limited data 
available to better target IRS interventions.
The primary challenge in developing the IRMP has 
been a lack of options for insecticide rotation. Ideally, in-
secticides that have different modes of action should be al-
ternated or used in a mosaic to reduce selection pressure. 
However, only 4 classes of insecticides with 2 modes of ac-
tion are currently recommended for IRS. The primary vec-
tors in Zambia have different cross-resistance patterns, and 
their ranges overlap throughout much of the country, mak-
ing the choice for control limited in an insecticide-based 
program. Industry must continue to develop new classes of 
insecticides that can be used in a public health context. The 
Innovative Vector Control Consortium (11,29) is a public-
private partnership that has made great strides in this en-
deavor. Another strategy that may lessen selection pressure 
on a single insecticide is the use of larvicides, for which 
more options are currently available than for adulticides. If 
larvicides become an important part of the vector control 
program in the future, resulting data will need to be incor-
porated into the IRMP.
Discussion
The impact of the policy changes (i.e., to alternate insec-
ticides and cease pyrethroid use) on the reversal of re-
sistance, mosquito abundance, and malaria incidence is 
currently being monitored, and preliminary results are 
promising. In some areas of Eastern province, before the 
switch to Actellic 300CS, An. funestus sensu lato mos-
quitoes showed a very high intensity of resistance to del-
tamethrin (up to 40% survival at 10 times the diagnostic 
dose by using CDC intensity assays). Currently, after 2 
years of organophosphate spraying, preliminary results 
indicate a substantial reduction in the intensity of resis-
tance to deltamethrin. Because resistance mechanisms are 
generally considered biologically costly (30), deltame-
thrin resistance may be decreasing in the absence of any 
strong pyrethroid selection pressure. However, monitor-
ing is needed to confirm the reversal of resistance and to 
establish the causative mechanism. The effects of the pol-
icy on entomologic and epidemiologic parameters are still 
being monitored; recently increased efforts include quan-
tifying entomologic indicators of transmission throughout 
sprayed areas and conducting biannual malaria indicator 
surveys to track disease trends over time.
A key to the success of Zambia’s insecticide resis-
tance management policy development has been the es-
tablishment of a multidisciplinary IRMTWG and the ex-
pertise of the TAC. These 2 bodies serve as the fulcrum 
of the entire policy development process by defining ob-
jectives, reviewing progress, and actively responding to 
feedback from policy implementers. This oversight has 
resulted in effective collaborations among stakeholders 
and has facilitated accumulation of entomologic data, 
greater understanding of resistance mechanisms, and es-
tablishment of a shared database for insecticide resistance 
data. However, the success of this policy change relies 
on continued investment in monitoring and evaluation, 
industry’s development of insecticides with new modes 
of action, and the building of capacity and infrastructure 
so that reliance on donor funding and resources can be 
lessened in the future. Although sentinel sites for entomo-
logic monitoring increased over time on a national scale, 
adoption of more cost-effective monitoring schemes, such 
as community-based surveillance (31), is needed to en-
sure sustainability.
Insecticide resistance will contribute to disease re-
emergence if not managed appropriately (5). Although the 
malaria control community is currently at the forefront of 
this issue, other vectorborne infections for which control 
measures rely heavily on the use of insecticides should be 
proactively mitigating the effects of insecticide resistance 
on transmission. Other vectorborne infections that are en-
demic in Zambia (e.g., lymphatic filariasis and dengue) do 
not have control programs that implement vector control. 
However, dengue control in other areas relies extensively 
on the use of insecticides to control immature stages of in-
sects, and resistance to organophosphates and pyrethroids 
is widespread in the primary vector Aedes aegypti mos-
quitoes (32). The control of triatomine bugs that trans-
mit Chagas disease is primarily accomplished through the 
spraying of residual insecticides in houses (33). However, 
pyrethroid-resistant vector populations are now wide-
spread (34). Visceral leishmaniasis, a disease transmit-
ted by phlebotomine sandflies, is also largely controlled 
by IRS, but various populations have been found to be 
resistant to the insecticides used in these applications 
(35,36). Resistance monitoring and management must be 
integrated into all vectorborne disease control programs 
so that available insecticides can be used judiciously and 
the efficacy of chemical-based control can be sustained 
for the long term.
Acknowledgments
We acknowledge the contributions of time and resources of all 
members of working groups and advisory committees.
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	22,	No.	5,	May	2016	 777
PERSPECTIVE
This work was supported by the President’s Malaria Initiative,  
which provided funding to the Zambia Integrated Systems 
Strengthening Program.
Dr. Chanda is a medical entomologist and vector control special-
ist. His interests include vectorborne disease epidemiology; de-
sign, implementation, monitoring, and evaluation of control pro-
grams; and insecticide resistance and entomologic surveillance 
in the context of integrated vector management. Mr. Thomsen is 
a vector biologist at the Liverpool School of Tropical Medicine. 
His work focuses on operational research to deliver effective 
vectorborne disease control and use of information technology to 
support control programs.
References
  1. Gratz NG. Emerging and resurging vector-borne diseases.  
Annu Rev Entomol. 1999;44:51–75. http://dx.doi.org/10.1146/ 
annurev.ento.44.1.51
  2. Morse SS. Factors in the emergence of infectious diseases. Emerg 
Infect Dis. 1995;1:7–15. http://dx.doi.org/10.3201/eid0101.950102
  3. Hemingway J, Ranson H. Insecticide resistance in insect vectors  
of human disease. Annu Rev Entomol. 2000;45:371–91. 
http://dx.doi.org/10.1146/annurev.ento.45.1.371
  4. Ranson H, N’guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V. 
Pyrethroid resistance in African anopheline mosquitoes: what are 
the implications for malaria control? Trends Parasitol. 2011;27:91–
8. http://dx.doi.org/10.1016/j.pt.2010.08.004
  5. Cohen JM, Smith DL, Cotter C, Ward A, Yamey G, Sabot OJ,  
et al. Malaria resurgence: a systematic review and assessment of  
its causes. Malar J. 2012;11:122. http://dx.doi.org/10.1186/ 
1475-2875-11-122
  6. Harrus S, Baneth G. Drivers for the emergence and re-emergence 
of vector-borne protozoal and bacterial diseases. Int J Parasitol. 
2005;35:1309–18. http://dx.doi.org/10.1016/j.ijpara.2005.06.005
  7. Liu N. Insecticide resistance in mosquitoes: impact, mechanisms, 
and research directions. Annu Rev Entomol. 2015;60:537–59. 
http://dx.doi.org/10.1146/annurev-ento-010814-020828
  8. McCann RS, Ochomo E, Bayoh MN, Vulule JM, Hamel MJ, 
Gimnig JE, et al. Reemergence of Anopheles funestus as a vector of 
Plasmodium falciparum in western Kenya after long-term  
implementation of insecticide-treated bed nets. Am J Trop Med 
Hyg. 2014;90:597–604. http://dx.doi.org/10.4269/ajtmh.13-0614
  9. Hemingway J. The role of vector control in stopping the  
transmission of malaria: threats and opportunities. Philos Trans 
R Soc Lond B Biol Sci. 2014;369:20130431. http://dx.doi.org/ 
10.1098/rstb.2013.0431
10. World Health Organization. Global plan for insecticide resistance 
management in malaria vectors. Geneva: The Organization; 2012.
11. Mnzava AP, Knox TB, Temu EA, Trett A, Fornadel C,  
Hemingway J, et al. Implementation of the global plan for  
insecticide resistance management in malaria vectors: progress, 
challenges and the way forward. Malar J. 2015;14:173.  
http://dx.doi.org/10.1186/s12936-015-0693-4
12. Snow RW, Marsh K. Malaria in Africa: progress and prospects in 
the decade since the Abuja Declaration. Lancet. 2010;376:137–9. 
http://dx.doi.org/10.1016/S0140-6736(10)60577-6
13. Sharp B, van Wyk P, Sikasote JB, Banda P, Kleinschmidt I.  
Malaria control by residual insecticide spraying in Chingola and  
Chililabombwe, Copperbelt Province, Zambia. Trop Med Int 
Health. 2002;7:732–6. http://dx.doi.org/10.1046/ 
j.1365-3156.2002.00928.x
14. Chanda E, Masaninga F, Coleman M, Sikaala C, Katebe C, 
Macdonald M, et al. Integrated vector management: the Zambian 
experience. Malar J. 2008;7:164. http://dx.doi.org/10.1186/ 
475-2875-7-164
15. Chanda E, Mukonka VM, Kamuliwo M, Macdonald MB,  
Haque U. Operational scale entomological intervention for  
malaria control: strategies, achievements and challenges in  
Zambia. Malar J. 2013;12:10. http://dx.doi.org/10.1186/ 
1475-2875-12-10
16. Zambia Ministry of Health. Zambia National Malaria Indicator  
Survey 2012. Lusaka (Zambia): The Ministry; 2012.
17. Chanda E, Hemingway J, Kleinschmidt I, Rehman AM,  
Ramdeen V, Phiri FN, et al. Insecticide resistance and the future  
of malaria control in Zambia. PLoS One. 2011;6:e24336.  
http://dx.doi.org/10.1371/journal.pone.0024336
18. World Health Organization. Test procedures for insecticide  
resistance monitoring in malaria vector mosquitoes. Geneva:  
The Organization; 2013.
19. Toé KH, Jones CM, N’Fale S, Ismail HM, Dabiré RK,  
Ranson H. Increased pyrethroid resistance in malaria vectors and 
decreased bed net effectiveness, Burkina Faso. Emerg Infect Dis. 
2014;20:1691–6. http://dx.doi.org/10.3201/eid2010.140619
20. Centers for Disease Control and Prevention. Guideline for  
evaluating insecticide resistance in vectors using the CDC bottle 
bioassay. Atlanta: The Centers; 2010.
21. Hemingway J, Vontas J, Poupardin R, Raman J, Lines J,  
Schwabe C, et al. Country-level operational implementation of the 
Global Plan for Insecticide Resistance Management.  
Proc Natl Acad Sci U S A. 2013;110:9397–402. http://dx.doi.org/ 
10.1073/pnas.1307656110
22. Thomsen EK, Strode C, Hemmings K, Hughes AJ, Chanda E,  
Musapa M, et al. Underpinning sustainable vector control 
through informed insecticide resistance management. PLoS One. 
2014;9:e99822. http://dx.doi.org/10.1371/journal.pone.0099822
23. Hargreaves K, Koekemoer LL, Brooke BD, Hunt RH, Mthembu J, 
Coetzee M. Anopheles funestus resistant to pyrethroid insecticides 
in South Africa. Med Vet Entomol. 2000;14:181–9.  
http://dx.doi.org/10.1046/j.1365-2915.2000.00234.x
24. Wondji CS, Coleman M, Kleinschmidt I, Mzilahowa T, Irving H,  
Ndula M, et al. Impact of pyrethroid resistance on operational  
malaria control in Malawi. Proc Natl Acad Sci U S A. 2012; 
109:19063–70. http://dx.doi.org/10.1073/pnas.1217229109
25. Cuamba N, Morgan JC, Irving H, Steven A, Wondji CS. High level 
of pyrethroid resistance in an Anopheles funestus population of the 
Chokwe District in Mozambique. PLoS One. 2010;5:e11010. 
http://dx.doi.org/10.1371/journal.pone.0011010
26. Eisen L, Coleman M, Lozano-Fuentes S, McEachen N, Orlans M, 
Coleman M. Multi-disease data management system platform for 
vector-borne diseases. PLoS Negl Trop Dis. 2011;5:e1016.  
http://dx.doi.org/10.1371/journal.pntd.0001016
27. Thomsen E, Deb RM, Dunkley S, Coleman M, Foster GM,  
Orlans M, et al. Enhancing decision-support for vector-borne 
disease control programs—the Disease Data Management System. 
PLoS Negl Trop Dis. 2016;10:e0004342 http://dx.doi.org/10.1371/
journal.pntd.0004342. 
28. Zambia Ministry of Health. 2011 Malaria annual report. Lusaka 
(Zambia): The Ministry; 2012.
29. Hemingway J, Beaty BJ, Rowland M, Scott TW, Sharp BL.  
The Innovative Vector Control Consortium: improved control of 
mosquito-borne diseases. Trends Parasitol. 2006;22:308–12.  
http://dx.doi.org/10.1016/j.pt.2006.05.003
30. Rivero A, Vézilier J, Weill M, Read AF, Gandon S. Insecticide  
control of vector-borne diseases: when is insecticide resistance 
a problem? PLoS Pathog. 2010;6:e1001000. http://dx.doi.org/ 
10.1371/journal.ppat.1001000
31. Sikaala CH, Chinula D, Chanda J, Hamainza B, Mwenda M, 
Mukali I, et al. A cost-effective, community-based, mosquito- 
trapping scheme that captures spatial and temporal heterogeneities 
778	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	22,	No.	5,	May	2016
Insecticide	Resistance	Management	Planning
of malaria transmission in rural Zambia. Malar J. 2014;13:225. 
http://dx.doi.org/10.1186/1475-2875-13-225
32. Ranson H, Burhani J, Lumjuan N, Black WC. Insecticide resistance 
in dengue vectors. TropIKA.net. 2010 Mar (cited 2016 Jan 4). 
http://journal.tropika.net/scielo.php?script=sci_arttext&pid= 
S2078-86062010000100003&lng=en
33. Gürtler RE, Kitron U, Cecere MC, Segura EL, Cohen JE.  
Sustainable vector control and management of Chagas disease  
in the Gran Chaco, Argentina. Proc Natl Acad Sci U S A. 
2007;104:16194–9. http://dx.doi.org/10.1073/pnas.0700863104
34. Pedrini N, Mijailovsky SJ, Girotti JR, Stariolo R, Cardozo RM, 
Gentile A, et al. Control of pyrethroid-resistant Chagas  
disease vectors with entomopathogenic fungi. PLoS Negl  
Trop Dis. 2009;3:e434. http://dx.doi.org/10.1371/ 
journal.pntd.0000434
35. Dinesh DS, Das ML, Picado A, Roy L, Rijal S, Singh SP, et al. 
Insecticide susceptibility of Phlebotomus argentipes in visceral 
leishmaniasis endemic districts in India and Nepal. PLoS Negl Trop 
Dis. 2010;4:e859. http://dx.doi.org/10.1371/journal.pntd.0000859
36. Hassan MM, Widaa SO, Osman OM, Numiary MS, Ibrahim MA, 
Abushama HM. Insecticide resistance in the sand fly, Phlebotomus 
papatasi from Khartoum state, Sudan. Parasit Vectors. 2012;5:46. 
http://dx.doi.org/10.1186/1756-3305-5-46
Address for correspondence: Edward Thomsen, Liverpool School of 
Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK;  
email: edward.thomsen@lstmed.ac.uk; Michael Coleman, Liverpool 
School of Tropical Medicine, Pembroke Pl, Liverpool L3 5QA, UK; 
email: michael.coleman@lstmed.ac.uk 
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	22,	No.	5,	May	2016	 779
May 2015: Vectorborne Infections
Including:
• Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012
• Recent US Case of Variant Creutzfeldt-Jakob Disease—Global Implications
• Novel Thogotovirus Associated with Febrile Illness and Death, United States, 2014
• A(H7N9) Virus Beyond China
•  Pathologic Changes in Wild Birds  
Infected with Highly Pathogenic  
Avian Influenza (H5N8) Viruses, South 
Korea, 2014
•  Itaya virus, a Novel Orthobunyavirus 
Associated with Human  Febrile  
Illness, Peru
•  Isolation of Onchocerca lupi in Dogs 
and Black Flies, California, USA
•  Molecular Epidemiology of Plasmodium 
falciparum Malaria Outbreak,  
Tumbes, Peru, 2010–2012
•  Delayed-Onset Hemolytic Anemia in 
Patients with Travel-Associated Severe 
Malaria Treated with Artesunate, 
France, 2011–2013
•  Protective Antibodies against Placental 
Malaria and Poor Outcomes during 
Pregnancy, Benin
http://wwwnc.cdc.gov/eid/articles/issue/21/05/table-of-contents
